Profile
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved solubility of APIs and extended release. Validated as an eye drop, with successful pre-clinical studies in glaucoma, dry eye and uveitis, 20/20 OptimEyes is seeking partners to further develop these assets or those with novel or repurposed APIs targeting mucosal areas for co-development opportunities.
Website
2020optimeyes.caContact
-
Frances Lasowski, Chief Executive Officer and Co-FounderTel: +1 905-978-9262Email: frances@2020optimeyes.ca
-
-
-
-
-
Event details
Date: December 1 - 5, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
13 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
-
Atorvia is pioneering first-in-class peptide therapeutics that treat organ failure, beginning with acute kidney… -
Aufero Medical is a Canadian medtech startup developing TruContact, a robotic tool that actively stabilizes… -
Cosm Medical is digitizing gynecological devices to personalize care for pelvic health issues that affect half of… -
Eurofins CDMO Alphora develops and manufactures small molecule and biologic drug substances and drug… -
Inertia is an award-winning Canadian med-device development services firm that helps medical and diagnostic… -
JN Nova's Two JN2019 Development Leads: A novel Long COVID therapeutic is scheduled to… -
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science… -
MEMOTEXT is a platform for co-creating digital patient engagement tools that personalize and scale evidence-based… -
Helping Biotech companies beat the odds - Omnium Global is an innovation company advancing life sciences through… -
Pulse Infoframe is a global healthcare company with a best-in-class real-world evidence platform that has… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
VeriLuce Therapeutics is a biotech company focusing on the development of novel small molecules targeting in dual…